BD Welcomes Pamela Spikner as Chief Accounting Officer
BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent player in the global medical technology arena, has announced a significant leadership addition with Pamela Spikner stepping into the role of Chief Accounting Officer and Controller. This strategic move is part of BD's ongoing commitment to enhancing its financial leadership as the company continues to grow and evolve.
Role and Responsibilities of Pamela Spikner
In her new position, Pamela will oversee all accounting policies and financial reporting efforts for BD. Reporting directly to Chris DelOrefice, the executive vice president and chief financial officer, Spikner's role is crucial in maintaining the integrity and accuracy of the company's financial activities.
Pam's Wealth of Experience
Spikner joins BD with a strong background, having previously served as Chief Accounting Officer at R1 RCM, Inc., a company providing innovative revenue cycle management solutions. During her tenure there, she led financial reporting initiatives and compliance efforts while optimizing financial performance through strategic planning and operational efficiencies.
Previous Leadership Positions
Before her role at R1 RCM, Pamela held several key positions at Exelon Corporation, a Fortune 200 company, where she played a vital role in their financial leadership for over 12 years. Additionally, she served as the assistant corporate controller at Hill-Rom Holdings, Inc., a recognized name in the medical device sector. Spikner began her career in the auditing practice of PwC, gaining experience in the healthcare and insurance fields.
Pam Spikner’s Educational Background and Credentials
Pam earned her Bachelor of Science degree in Accounting from Indiana University of Pennsylvania. She is a certified public accountant (CPA) and also holds a certification as a certified internal auditor (CIA), underscoring her extensive knowledge and qualifications in the finance sector.
About BD and Its Mission
BD is not just a medical technology company; it is at the forefront of advancing health globally. With a dedicated workforce of more than 70,000 individuals, BD strives to improve medical discovery and diagnostics. The company is committed to supporting front-line healthcare heroes by developing technologies and solutions that enhance patient therapy and operational efficiencies for healthcare providers.
In pursuit of its mission, BD collaborates with various organizations globally, tackling some of the most pressing health challenges. By fostering partnerships, BD aims to improve healthcare delivery while ensuring safety and efficiency in treatment processes.
Contact Information
For further inquiries, media contacts include:
Troy Kirkpatrick
VP, Public Relations
Phone: 858.617.2361
Adam Reiffe
Senior Director, Investor Relations
Phone: 201.847.6927
Frequently Asked Questions
Who is Pamela Spikner?
Pamela Spikner is the newly appointed Chief Accounting Officer and Controller at BD, bringing over 25 years of leadership experience in finance.
What role will Pamela Spikner fulfill at BD?
She will oversee all accounting policies and financial reporting, reporting to the CFO, Chris DelOrefice.
Where did Pamela Spikner work before joining BD?
Prior to BD, she served as Chief Accounting Officer at R1 RCM, Inc., and held various positions at Exelon Corporation and Hill-Rom Holdings, Inc.
What are Pamela's educational qualifications?
Pamela holds a Bachelor of Science in Accounting and is a certified public accountant and certified internal auditor.
What is BD's primary mission?
BD aims to advance health globally through innovation in medical technologies, supporting healthcare providers and enhancing patient outcomes.
